POST COVID-19 POTS Study
Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult patients with Post–COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: Yes
CONDITION: Postural Orthostatic Tachycardia Syndrome, POTS
This study is examining the safety of an investigational drug in people with POST COVID-19 postural orthostatic tachycardia syndrome (POTS) and how well people tolerate it. It is also looking at how well the study drug works and is processed in people who have post-COVID-19 POST COVID-19 POTS.
Who Can Participate
Participants 18 years of age and older who have diagnosed with new-onset POTS post-COVID-19 may be eligible for this study.
- StudyID# 20221280